Page last updated: 2024-11-04

sulfinpyrazone and Thrombocythemia

sulfinpyrazone has been researched along with Thrombocythemia in 3 studies

Sulfinpyrazone: A uricosuric drug that is used to reduce the serum urate levels in gout therapy. It lacks anti-inflammatory, analgesic, and diuretic properties.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19903 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bogousslavsky, J1
Regli, F1
Rousselle, J1
Schmidt, PM1
Barnett, HJ1
Hirsh, J1
Gent, M1
Genton, E1

Reviews

1 review available for sulfinpyrazone and Thrombocythemia

ArticleYear
The pathophysiology of transient cerebral ischemic attacks.
    The Medical clinics of North America, 1979, Volume: 63, Issue:4

    Topics: Arteriosclerosis; Aspirin; Carotid Arteries; Cerebrovascular Disorders; Cholesterol; Embolism; Endoc

1979

Trials

1 trial available for sulfinpyrazone and Thrombocythemia

ArticleYear
The current status of platelet suppressive drugs in the treatment of thrombosis.
    Thrombosis et diathesis haemorrhagica, 1975, Jun-30, Volume: 33, Issue:3

    Topics: Aged; Arteriovenous Shunt, Surgical; Aspirin; Blood Platelets; Cardiac Catheterization; Cell Surviva

1975

Other Studies

1 other study available for sulfinpyrazone and Thrombocythemia

ArticleYear
[Cerebrovascular complications of thrombocytosis].
    Schweizerische medizinische Wochenschrift, 1983, Apr-09, Volume: 113, Issue:14

    Topics: Aged; Aspirin; Blindness; Cerebellar Diseases; Cerebellopontine Angle; Facial Paralysis; Female; Hum

1983